3 Magnificent Growth Stocks to Buy Hand Over Fist

Core Viewpoint - Small-cap stocks are expected to benefit from anticipated rate cuts by the central bank in 2025, presenting potential investment opportunities in this sector [1] Group 1: Small-Cap Stocks Overview - Small-cap and mid-cap stocks are sensitive to interest rates due to their reliance on debt instruments for long-term financial obligations [1] - The Federal Reserve is expected to cut rates by 2025, which could serve as a catalyst for smaller companies struggling in a high-rate environment [1] Group 2: Agenus - Agenus is a small-cap immunology company with a market cap of $224 million, focusing on an antibody cocktail for advanced metastatic colorectal cancer [2] - The company aims for an accelerated regulatory filing and plans to expand its total addressable market, potentially transforming its therapy into a multi-billion-dollar revenue source [2] - Recent cash infusion from Ligand Pharmaceuticals provides Agenus with the necessary funds to reach important regulatory milestones and other clinical catalysts in 2025 [3] Group 3: Canopy Growth - Canopy Growth, a Canadian cannabis cultivator, has seen its shares nearly double this year due to the U.S. proposal to reclassify cannabis under the Controlled Substances Act [4] - Despite being based in Canada, Canopy plans to enter the U.S. market once legal conditions allow, indicating a long-term growth strategy [4] - The stock may not appeal to short-term investors, but its long-term strategy positions it as a significant player in the global marijuana market [4] Group 4: Curaleaf Holdings - Curaleaf Holdings is recognized as a leading cannabis company with a market cap of $4.1 billion, holding a strong position in both Europe and the U.S. [5] - The cumulative commercial opportunity in these markets is estimated to be nearly $300 billion, highlighting significant growth potential [5] - Curaleaf's status as a frontrunner in international expansion among U.S. multi-state operators presents generational wealth-building potential for long-term shareholders [5][6]